Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia.
Clift
R A
RA
Buckner
C D
CD
Appelbaum
F R
FR
Sullivan
K M
KM
Storb
R
R
Thomas
E D
ED
D000208:Acute Disease; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D001989:Bronchiolitis Obliterans / Q000209:etiology; D002283:Carcinoma, Bronchogenic; D003520:Cyclophosphamide / Q000627:therapeutic use; D018572:Disease-Free Survival; D004307:Dose-Response Relationship, Radiation; D005500:Follow-Up Studies; D006086:Graft vs Host Disease / Q000209:etiology / Q000401:mortality; D006801:Humans; D007951:Leukemia, Myeloid / Q000401:mortality / Q000628:therapy*; D015993:Life Tables; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology / Q000628:therapy; D016609:Neoplasms, Second Primary; D011879:Radiotherapy Dosage; D012074:Remission Induction; D016019:Survival Analysis; D019172:Transplantation Conditioning / Q000009:adverse effects / Q000379:methods*; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D014916:Whole-Body Irradiation / Q000009:adverse effects / Q000379:methods*
D003520:Cyclophosphamide